The immune system speaks. We Listen
MeMed is transforming patient care by listening to the immune system and turning host response signals into clinical action.
We developed a pioneering test to help physicians with the seemingly simple clinical dilemma - is it a bacterial or viral infection?
By providing host response information, we help physicians make more informed decisions about how and when to treat. From a small serum sample, MeMed BV computationally integrates the level of three host immune proteins into a simple score indicating the likelihood of a bacterial immune response or co-infection versus a likely virtual immune response.
Conventional tests are often insufficient because...
Inaccessible infection sites
Often no pathogens are detected
False alarms due to colonization
Prolonged time to results
Uncertainty regarding severity
A cutting-edge technology, compact, multi-purpose platform quantitative diagnostic immunoassays that open the way to central lab performance at the point of need, using chemiluminescence detection technology.
MeMed Key runs the MeMed BV™ test within 15 minutes.
*MeMed BV® test and the MeMed Key® platform, have both been granted 510(k) clearance by the U.S. @FDA
At MeMed, a leader in host response technologies, we decode the body's complex signals into simple insights that improve people's lives. By leveraging our expertise in host-response profiling and machine-learning algorithms, we are creating a portfolio of tests that address tough clinical dilemmas.